2012
DOI: 10.1038/jhg.2012.77
|View full text |Cite
|
Sign up to set email alerts
|

Subtelomeric deletions of 1q43q44 and severe brain impairment associated with delayed myelination

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 18 publications
1
16
0
Order By: Relevance
“…The phenotype in this case represents a subset of the phenotype described in the case report by Perrone et al [5]. The deletion in our patient includes a 380 kb upstream region and the first four exons of CHRM3, whereas the deleted region present in patients reported by Perrone et al [5] and Shimojima et al [2], includes all 5 exons of CHRM3. Both children exhibit intellectual disability, autistic features, feeding difficulties and strabismus.…”
Section: Discussionmentioning
confidence: 53%
See 3 more Smart Citations
“…The phenotype in this case represents a subset of the phenotype described in the case report by Perrone et al [5]. The deletion in our patient includes a 380 kb upstream region and the first four exons of CHRM3, whereas the deleted region present in patients reported by Perrone et al [5] and Shimojima et al [2], includes all 5 exons of CHRM3. Both children exhibit intellectual disability, autistic features, feeding difficulties and strabismus.…”
Section: Discussionmentioning
confidence: 53%
“…3. The clinical manifestations of the case reported by Perrone et al [5] and Shimojima et al [2], along with the present case are presented in Table 1.…”
Section: Resultsmentioning
confidence: 73%
See 2 more Smart Citations
“…Orellana et al [2009] reported one patient with the clinical and molecular findings consistent with a role for AKT3 in corpus callosum development. Shimojima et al [2012] also described 6 patients with ACC and 1q44 deletion including AKT3 . Boland et al [2007] sequenced AKT3 in 45 patients and no mutations were found.…”
Section: Discussionmentioning
confidence: 99%